一例利伐沙班相关的自发性血胸。
A case of rivaroxaban associated spontaneous hemothorax.
作者信息
Yıldız İbrahim, Aksu Ebubekir, Özmen Yıldız Pınar Özmen, Gürbak İsmail
机构信息
Department of Cardiology, Osmaniye State Hospital, Osmaniye, Turkey.
Department of Thoracic Surgery, Osmaniye State Hospital, Osmaniye, Turkey.
出版信息
Turk Gogus Kalp Damar Cerrahisi Derg. 2019 Jan 1;27(1):118-120. doi: 10.5606/tgkdc.dergisi.2019.15090. eCollection 2019 Jan.
Abstract
New oral anticoagulants have emerged as an alternative for warfarin for thromboembolic prevention in patients with nonvalvular atrial fibrillation. Although new oral anticoagulants have better compliance and safety margin compared to warfarin, we must be cautious with their usage. In this article, we report a case of spontaneous hemothorax related to rivaroxaban treatment. According to our research, this is the first case of spontaneous hemothorax secondary to rivaroxaban treatment.
摘要
新型口服抗凝药已成为华法林的替代药物，用于非瓣膜性心房颤动患者的血栓栓塞预防。尽管新型口服抗凝药与华法林相比具有更好的依从性和安全边际，但我们在使用时仍须谨慎。在本文中，我们报告了一例与利伐沙班治疗相关的自发性血胸病例。根据我们的研究，这是首例继发于利伐沙班治疗的自发性血胸病例。
相似文献
1
A case of rivaroxaban associated spontaneous hemothorax.
Turk Gogus Kalp Damar Cerrahisi Derg. 2019 Jan 1;27(1):118-120. doi: 10.5606/tgkdc.dergisi.2019.15090. eCollection 2019 Jan.
2
Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
Circulation. 2015 Sep 29;132(13):1252-60. doi: 10.1161/CIRCULATIONAHA.115.015710. Epub 2015 Jul 21.
3
Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation.
Am J Med. 2019 May;132(5):596-604.e11. doi: 10.1016/j.amjmed.2018.12.023. Epub 2019 Jan 9.
4
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients.
Stroke. 2018 Dec;49(12):2933-2944. doi: 10.1161/STROKEAHA.118.020232.
5
Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
Circulation. 2014 Jul 8;130(2):138-46. doi: 10.1161/CIRCULATIONAHA.113.005008. Epub 2014 Jun 3.
6
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.
J Am Heart Assoc. 2016 Jun 13;5(6):e003725. doi: 10.1161/JAHA.116.003725.
7
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation.
J Am Heart Assoc. 2018 Apr 13;7(8):e008643. doi: 10.1161/JAHA.118.008643.
8
Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis.
Am J Med. 2019 Sep;132(9):1078-1083. doi: 10.1016/j.amjmed.2019.04.013. Epub 2019 May 2.
9
Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients.
Curr Med Res Opin. 2017 Oct;33(10):1745-1754. doi: 10.1080/03007995.2017.1334638. Epub 2017 Aug 29.
10
Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation.
Stroke. 2019 Aug;50(8):2245-2249. doi: 10.1161/STROKEAHA.119.025536. Epub 2019 Jun 18.
引用本文的文献
1
Rivaroxaban-induced spontaneous hemothorax: a rare case report and literature review.
Front Med (Lausanne). 2025 Jul 29;12:1641092. doi: 10.3389/fmed.2025.1641092. eCollection 2025.
2
Sudden hemothorax as a rare initial manifestation of bronchiectasis under a direct oral anticoagulant.
Surg Case Rep. 2022 Sep 23;8(1):175. doi: 10.1186/s40792-022-01536-0.
3
Spontaneous hemothorax caused by concomitant low-dose rivaroxaban and itraconazole in a 95-year-old patient: case report and literature review.
J Int Med Res. 2021 Sep;49(9):3000605211047712. doi: 10.1177/03000605211047712.
本文引用的文献
1
Etiology and management of spontaneous haemothorax.
J Thorac Dis. 2015 Mar;7(3):520-6. doi: 10.3978/j.issn.2072-1439.2014.12.50.
2
Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment.
Clin Pharmacokinet. 2013 Apr;52(4):243-54. doi: 10.1007/s40262-013-0034-0.
3
Laboratory assessment of novel oral anticoagulants: method suitability and variability between coagulation laboratories.
Clin Chem. 2013 May;59(5):807-14. doi: 10.1373/clinchem.2012.198788. Epub 2013 Feb 1.
4
Review of recently approved alternatives to anticoagulation with warfarin for emergency clinicians.
J Emerg Med. 2013 Jul;45(1):143-9. doi: 10.1016/j.jemermed.2012.11.032. Epub 2013 Jan 30.
5
[A rare complication of oral anticoagulant treatment: hemothorax].
Tuberk Toraks. 2012;60(1):70-3. doi: 10.5578/tt.2463.
6
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.
7
Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor.
Br J Clin Pharmacol. 2010 Nov;70(5):703-12. doi: 10.1111/j.1365-2125.2010.03753.x.
8
Spontaneous hemothorax: a comprehensive review.
Chest. 2008 Nov;134(5):1056-1065. doi: 10.1378/chest.08-0725.
9
Population model of the pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor xa inhibitor--in healthy subjects.
Int J Clin Pharmacol Ther. 2007 Jun;45(6):335-44. doi: 10.5414/cpp45335.
10
[Hemothorax with high number of eosinophils following warfarin overdose].
Pneumonol Alergol Pol. 2002;70(9-10):496-503.
Zotero 插件